Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Astria Therapeutics, Inc. (CATB) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Astria Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1454789.
Total stock buying since 2015: $63,789,794.
Total stock sales since 2015: $247,304.
Total stock option exercises since 2015: $77,400.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 2,481,350 | $29,999,521 | 20,000 | $247,304 | 20,000 | $77,400 |
| 2023 | 1,814,608 | $11,587,996 | 0 | $0 | 0 | $0 |
| 2021 | 100 | $669 | 0 | $0 | 0 | $0 |
| 2015 | 1,850,134 | $22,201,608 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-04 | 0 | $0 | 10,000 | $135,940 | 10,000 | $38,700 |
| 2024-02 | 2,481,350 | $29,999,521 | 0 | $0 | 0 | $0 |
| 2024-01 | 0 | $0 | 10,000 | $111,364 | 10,000 | $38,700 |
| 2023-12 | 740,000 | $4,588,000 | 0 | $0 | 0 | $0 |
| 2023-10 | 1,074,608 | $6,999,996 | 0 | $0 | 0 | $0 |
| 2021-11 | 100 | $669 | 0 | $0 | 0 | $0 |
| 2015-06 | 1,850,134 | $22,201,608 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-04-01 | Morabito Christopher (Chief Medical Officer) | Sale | 10,000 | 13.59 | 135,940 |
| 2024-04-01 | Morabito Christopher (Chief Medical Officer) | Option Ex | 10,000 | 3.87 | 38,700 |
| 2024-02-01 | Edelman Joseph (Director) | Buy | 2,481,350 | 12.09 | 29,999,521 |
| 2024-01-29 | Morabito Christopher (Chief Medical Officer) | Sale | 9,200 | 11.15 | 102,552 |
| 2024-01-29 | Morabito Christopher (Chief Medical Officer) | Option Ex | 9,200 | 3.87 | 35,604 |
| 2024-01-26 | Morabito Christopher (Chief Medical Officer) | Sale | 800 | 11.02 | 8,812 |
| 2024-01-26 | Morabito Christopher (Chief Medical Officer) | Option Ex | 800 | 3.87 | 3,096 |
| 2023-12-21 | Edelman Joseph (Director) | Buy | 740,000 | 6.20 | 4,588,000 |
| 2023-10-16 | Edelman Joseph (Director) | Buy | 1,074,608 | 6.51 | 6,999,996 |
| 2021-11-19 | Komjathy Andrew (Chief Commercial Officer) | Buy | 100 | 6.70 | 669 |
| 2015-06-30 | Laufer Ron (Director) | Buy | 223,439 | 12.00 | 2,681,268 |
| 2015-06-30 | Sv Life Sciences Fund V Strategic Partners, L.p. (10% Owner) | Buy | 391,090 | 12.00 | 4,693,080 |
| 2015-06-30 | Clarus Ventures Ii, Llc (10% Owner) | Buy | 376,695 | 12.00 | 4,520,340 |
| 2015-06-30 | Medimmune Ventures, Inc. (10% Owner) | Buy | 223,439 | 12.00 | 2,681,268 |
| 2015-06-30 | George Jean (Director) | Buy | 258,776 | 12.00 | 3,105,312 |
| 2015-06-30 | Galakatos Nicholas (Director) | Buy | 376,695 | 12.00 | 4,520,340 |
Insider trading activities including stock purchases, stock sales, and option exercises of CATB listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Astria Therapeutics, Inc. (symbol CATB, CIK number 1454789) see the Securities and Exchange Commission (SEC) website.